Summary.-During a population-based screening project for breast cancer, almost 15,000 women aged 50 years and over have provided a 12 h (overnight) sample of urine for research purposes. In 3,789 women the excretion of 11-desoxy-17-oxosteroids (DOOS) and creatinine was measured. Results were analysed in terms of urinary concentrations and of a ratio between DOOS and creatinine.
surface area had an effect on creatinine excretion and therefore on the ratio.
The following variables did not have an appreciable effect on the above-mentioned ratio: a family history of breast cancer, parity and age at first pregnancy, menopause and oestrogenic drugs, and parenchymal pattern of the breast as observed on the xeromammogram.
Breast cancer was found at first screening in 106 out of 14,697 women. In 100 of these cases DOOS and creatinine were measured. Excretion values expressed as the ratio between the two, allowing for body surface area, did not differ materially from those of 100 age-matched controls.
These results lead the authors to the conclusion that the determination of androgen metabolite excretion in women over 50 years of age is of no help in selecting a group at high risk of breast cancer.
EXTENSIVE WORK by Bulbrook et al. (1962) has drawn attention to the importance of androgen-metabolite excretion in the treatment of advanced breast cancer. These investigators also ventured the hypothesis that abnormal androgen metabolism might be of predictive value in assessing which women are at high risk of this disease. In 1961 they set up a prospective study on the island of Guernsey and collected 24h specimens of urine in over 5000 women. After a period of 10 years they published the findings in 27 women who had developed mammary cancer since the inception of the study, comparing them with a large number of controls. They concluded that low androgen-metabolite excretion might indicate a higher than normal risk of developing the disease (Bulbrook et al., 1971) .
On several occasions Bulbrook and coworkers expressed hope that determination of androgen metabolites in the urine might help in defining a high risk group when screening for breast cancer in a population (see Farewell (1977) and Farewell et al. (1978) ). We took up this point when we designed a large population study for the early detection of breast cancer in the city of Utrecht and its suburbs. Our aim was not only to test the predictiveness of 11 -desoxy 1 7-oxosteroid (DOOS) excretion in respect of breast cancer, but also to explore its possible relationships with known risk factors of this disease.
The early-detection study was designed after the success of combined physical examination and mammography in women over 50 years of age had been published by Shapiro et al. (1971) 50-66* (i.e. born 1911-1925) were investigated; the response rate for the first examination was 72%.
The investigation not only had immediate public health aims but also scientific ones. It is our belief that such large-scale undertakings should be used to learn more about the natural history of the disease. Thus the investigation comprised not only physical examination of the breasts and mammography (xeroradiography) but also a questionnaire with a number of items of epidemiological interest and a few somatometric measurements for assessing nutritional status.
In addition we asked the women to bring with them a bottle containing all urine collected from 8 pm on the previous day until after the first urine of the day of screening; 99.2% of women actually complied with our request.
From each urine specimen 2 samples of 250 ml were taken, frozen at -20°C, sealed in plastic bags and stored under a unique identification number at that temperature in a large refrigerating room outside the city.
From time to time samples were brought into the small laboratory of the Preventicon Centre for the semi-automated determination of DOOS (by the method described by Rademaker et al., 1976) and creatinine (Cr) (based on an automated Jaff6 reaction).
Following a suggestion by Miller et al. (1967) we measured total DOOS rather than one or more of the individual DOOSS, such as aetiocholanolone, androsterone or dehydroepi-androsterone.
The rationale of measuring creatinine was the immediate consequence of our decision to limit the urine collection period to about 12 h. It was thought too much of a burden for the women to collect 24h specimens. Thus, the results of DOOS determination were calculated in mg/l and also in terms of a DOOS/ Cr ratio.
In order to justify the latter procedure a pilot study was carried out by asking a number of women to provide not only the urine voided between 8 pm and 8 am (overnight urine) Since the number of urine specimens far exceeded the capacity of our laboratory, the following plani was made.
The intake of women in the study was divided into 5 successive study cohorts numbered I-V. Cohort I had its initial exainination during the first half of 1975, Cohort II during the second half of 1975, etc.
In Cohort I all urines (n=2171) were examined. From Cohorts II-IV 2 sets of samples were studied:
1. A randomly selected group (n 790) matched by day of screening, with 2. A compound high-risk group consisting of women Aith one or more risk factors (n= 828) such as previous history of breast biopsy, family history of breast cancer, late age at first pregnancy comnbined with definite overweight.
Moreover, the 12h urine specimeni of 100/ 106 women found to have mammary cancer through our screening effort could be analysed. An interesting feature of such a series is that the outcome can be equated more or less to a prospective study, since cancers N-ould have been found later (and in a different time order) if screening had niot been carried out.
Thus, in a way we had found an economic means of repeating the Guernsey study, thouigh in a somewrhat older groul) of w-oien. Fig. 3 .
The conclusion is entirely negative, in that we found no differences between those with a family history of mastectomy and controls. The same conclusion was reached for those aged 55 and over.
Since the sample is unbiased and its size is large, we are inclined to believe that this result, which adds the older age range to a smaller study by Bulbrook (1972) , is definite.
Parity and age at first pregnancy. In the analysis we have distinguished the nulliparous from the parous. In the former the unmarried have been separated from the ever-married women, and in the parous a division has been made between those who gave birth to their first child before and after 30 years of age respectively. The (Gehan & George, 1970) . Fig. 4 The results of the comparison are given in Fig. 5 a, age group (50-54 years) there is a slight suggestion for lower ratios in the control group, but this is possibly due to a few control women with large body size (and therefore high Cr excretion).
DISCUSSION
The present study has produced mainly negative results, in that we have not been able to substantiate Bulbrook's hypothesis on the possible selection of a high-risk group on the basis of androgen metabolite excretion.
It could be argued that our women were somewhat older (50-64 years) than those at Guernsey (35-55 years at entry). Judging from the paper of Bulbrook et al. (1971), the latter developed their cancer when they were between 40 and 60 years of age. Since then the number of breast cancers found in CGuernsey has increased to 45 (Farewell et al., 1978) and the risk of low androgen levels seems to hold for premenopausal women only (Bulbrook, personal communication).
For logistic reasons, 12h specimens were used in our study instead of 24h specimens. It was shown that the correlations between the DOOS/Cr ratio of 12 h arid 24 h specimens are very high (r=0.95), whereas this ratio in the 12h overnight sample explains about 50% of the variation of 24 h excretion of DOOS (r 0 72).
Creatinine measurements have been introduced as a means of controlling for individual dilution of urine. This introduces a problem in so far as Cr excretion itself is not independent of age and of body mass or size. These variables have been taken into account in comparing cases with controls.
Thus our results are free of this kind of bias. We are aware of the fact that there may be some day-to-day variation in the excretion of both creatinine (Vestergaard, 1978) and DOOS, although both are said to be fairly constant over time. Data are available on 461 women in whom a second 12 h sample was collected one year later. On the basis of urinary concentrations the correlation coefficient between the first and the second sample was 0 47 for DOOS and 0'38 for Cr. The issue of variability over time, however, is of theoretical rather than of practical interest when trying to identify a high risk group in population screening. Anxiety and stress might influence androgen-metabolite excretion. However, the majority of the Utrecht women screened for breast cancer for the first time in their lives experienced a degree of anxiety. In this respect the women found to have breast cancer were in the same position as the other women who did not have the disease.
Summarizing, we have not been able to find differences in the DOOS/Cr ratio which could be used to identify a group at high risk of breast cancer during a population-screening programme offered to a population of 50 years and over.
This does not imply that androgen metabolism is unrelated to the risk of breast cancer or to the course ofthe disease. It may be that the predictive value of androgen levels is greater in premenopausal than in postmenopausal women. For the time being, however, breastcancer screening is almost exclusive to the latter group.
